InvestorsHub Logo
Followers 177
Posts 24351
Boards Moderated 12
Alias Born 04/03/2002

Re: jedijazz post# 277

Wednesday, 07/29/2020 11:17:33 AM

Wednesday, July 29, 2020 11:17:33 AM

Post# of 3590
Very impressive news from CURR this week on this major acquisition of Sera Labs to significantly expand the company's capabilities and earnings power.

Note the comments from CEO Rob Davidson:

“Our acquisition of Sera Labs will add to CURE a growing brand portfolio and monetization platform that fits remarkably well with CURE’s development capabilities, products, and existing market verticals,” said Rob Davidson, CURE Pharmaceutical CEO. “By integrating Sera Labs’ products and processes with those of CURE’s, and leveraging our cGMP manufacturing facility to realize economies of scale, we will drive improved margins and profitability. This acquisition comes on the heels of our most recent pharmacokinetic study, which showed that that our CUREform thin film technology improved cannabidiol bioavailability, and sets the stage for potentially exciting opportunities to apply our innovative dosage forms to Sera Labs’ products. We look forward to joining the forces of the Sera Labs and CURE teams and to Nancy Duitch’s continued leadership at the helm of Sera Labs and as a key member of CURE‘s leadership team upon closing of the transaction.”